PharmEco Group of Companies

Search

RU | EN

BioJet – EN
  • About
    • General information
    • Administration
    • Pharmacovigilance
    • Business ethics
  • Production
  • Our products
  • News
  • Contacts

Mishustin: 90% of Essential Medicines Should Be Produced in Russia

According to the Prime Minister, this goal will be pursued as part of the national project “New Health Preservation Technologies.”

The share of domestically produced medicines from the list of essential and vital drugs (EVDL) in Russia should increase to 90% by 2030, Russian Prime Minister Mikhail Mishustin announced.

He noted that this effort will be conducted within the framework of the national project “New Health Preservation Technologies.”

“Activities under the national project ‘New Health Preservation Technologies’ will help expand the use of biomedical technologies, regenerative medicine methods, and improve access for citizens to advanced approaches in prevention and treatment. The share of domestically produced essential and vital medicines should increase to 90%,” said the Prime Minister while addressing the National Projects Council.

In April, during a report on the government’s work in 2023, Mishustin stated that the current share of domestically produced medicines from the EVDL list stands at 80%.

Source: TASS, December 5, 2024

Current news

  • March 31, 2025

    Russian spending on antidepressants reached nearly 3 billion rubles since the beginning of the year

    Pharmacy chains earned 2.8 billion rubles from antidepressant sales in January-February 2025. A total of…

  • March 31, 2025

    The State Duma rejected the bill on accelerated market entry for generics

    On March 20, deputies of the State Duma rejected in the first reading a bill…

  • March 31, 2025

    Russia to increase production of infliximab-based medicines

    The company “Pharmapark” plans to steadily increase its production volumes. Specifically, over 30,000 packages of…

  • March 31, 2025

    A unified database for veterinary drugs will be launched in EAEU countries

    The Collegium of the Eurasian Economic Commission (EEC) has approved the creation of a unified…

  • March 31, 2025

    MSD will pay up to $2 billion for Chinese heart medication

    One of the world’s largest pharmaceutical companies, MSD, will pay up to $2 billion for…

LLC “BioJet”. all rights reserved

  • Legal information